TFS Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-4,140
Closed -$311K 463
2017
Q2
$311K Sell
4,140
-12,428
-75% -$862K 0.12% 339
2017
Q1
$1.08M Sell
16,568
-959
-5% -$56.5K 0.35% 81
2016
Q4
$966K Buy
17,527
+9,623
+122% +$528K 0.26% 135
2016
Q3
$447K Sell
7,904
-19,740
-71% -$968K 0.11% 270
2016
Q2
$1.15M Sell
27,644
-10,812
-28% -$498K 0.21% 145
2016
Q1
$1.64M Buy
+38,456
New +$1.62M 0.24% 111
2015
Q4
Sell
-63,689
Closed -$2.47M 983
2015
Q3
$2.47M Buy
63,689
+12,834
+25% +$514K 0.24% 113
2015
Q2
$1.85M Buy
+50,855
New +$1.61M 0.18% 162

Other funds holding PRAH

TFS Capital's PRAH Position: Q3 2017 in Review

TFS Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2017, closing a stake of 4,140 shares — an estimated $311K sold.

TFS Capital first reported a position in PRAH in Q2 2015 and held it in 8 quarters. The position peaked at $2.47M in Q3 2015. 261 funds tracked by Wall St. Rank hold PRAH as of Q3 2017.

  • TFS Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 4,140 PRA Health Sciences, Inc. shares in Q3 2017, an estimated $311K.
  • TFS Capital first reported a position in PRA Health Sciences, Inc. in Q2 2015 and held it in 8 quarters.
  • TFS Capital's PRA Health Sciences, Inc. position peaked at $2.47M in Q3 2015.
  • 261 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.